Mitglieder

The competitiveness of Industrial Biotechnology processes is often hindered by the low performance of the microorganisms. To unlock the potential of this promising field, we must shift the paradigm and no longer adapt processes to the metabolic limitation of Industrial Microbial Hosts, but instead adapt microorganisms to industrial requirements.
Altar develops enabling technologies for the adaptation of microbial strains to industrial requirements. Our automated fluidic platform harnesses natural selection for the adaptive evolution of microorganisms. It has successfully proven to leverage metabolic engineering and non-GMO development for a wide range of organisms (bacteria, yeasts, microalgae) in several industrial fields (food, feed, chemicals, biofuels, materials, health, cosmetics…).

aquila biolabs is a German biotechnology start-up company focusing on the development of innovative laboratory devices for the control and analysis of bioprocesses in bioreactors and incubation shakers.
Our founding idea was a product for hassle-free biomass sensing, the Cell Growth Quantifier (CGQ). The CGQ is a sensor-based technology that offers highly parallelized, non-invasive online monitoring of biomass in shake flasks and bioreactors.
Our second product line, the Liquid Injection System (LIS), allows for automated feeding of liquids in shake flasks. This automated miniature pump is the first commercially available technology of its kind and can be used for a broad range of applications.
aquila biolabs was founded in 2014 and was ranked among the TOP 10 start-ups in Germany in 2015.

Autodisplay brings proteins and peptides to the surface of gram negative bacteria. The transport of molecules to the bacterial surface avoids protein expression issues such as inclusion bodies and incorrect folding.
With our proprietary cell surface display technology, we create custom-tailored solutions for our clients. Services include:
1. High-throughput screening of binding interactions and enhanced enzyme activity via FACS.
2. Development of whole cell biocatalysts that combine the benefits of soluble enzymes and classic whole cell biocatalysts – no limitations regarding permeability of substrate or product, yet easy recovery of the biocatalyst for re-use.
3. Functionalisation of solid surfaces with the highest levels of control regarding target molecule orientation. Autodisplay helps prevent the activity loss by-effect which occurs during immobilisation.

Axxence Aromatic was founded in 1986 and is a privately held company with head office in Emmerich, Germany. Over the years our focus has been of the dedication to be one of the most reliable and innovative sources within our prime field of expertise: NATURAL AROMA INGREDIENTS for the flavour & fragrance industry worldwide.
By strategic investments in R & D of both novel natural ingredients and new manufacturing processes, we constantly strive to expand the use of our products in existing and new applications as well as markets. Axxence has around 100 employees. Sales offices and warehousing are present in Germany, France, USA and Japan. Manufacturing and R & D facilities are located in the Slovak Republic.

b.fab is specialized in the efficient conversion of CO2 and hydrogen (H2) from renewable energy into biotechnological value chains. CO2 and water are abundantly available and therefore it is our starting point to build a sustainable bioeconomy. We use formate as our central mediator to bind and store CO2 and H2 (made from water) in liquid form. Our bioprocesses start with the feedstock formate and we use Synthetic Biology to design specific pathways and to convert formate into value-added chemicals. Our platform is built on anaerobic and aerobic microbial production hosts to provide flexibility in the process design and adaptation to specific product requirements. b.fab offers strains, bioprocesses and technology licences.

Bio Base Europe Pilot Plant ist ein innovativer Pilot- und Demonstrationsbetrieb für die Prozessentwicklung, das Scale-up und die kundenspezifische Herstellung von biobasierten Produkten und Prozessen. Das KMU kombiniert Technologien aus einem breiten und flexiblen Spektrum an modularen Betriebseinheiten aus den Bereichen Biomasse-Vorbehandlung, Biokatalyse, grüne Chemie, (Gas-)Fermentation, Bioraffinierung und Aufreinigung. Das Team aus hochqualifizierten Ingenieuren und Bioprozesstechnikern unterstützt den Kunden bei der Umsetzung der Laborprozesse in tragfähige industrielle Prozesse bis zum Multi-Tonnen Maßstab.
Von 2013-2019 wurden 322 bilaterale Projekte mit 124 KMUs und Großunternehmen erfolgreich durchgeführt und eine Beteiligung an mehr als 50 öffentlichen Projekten erreicht.

BIOMILLENIA, a France-based privately held company, is a leading technology solution provider for the development of novel green chemistry products. BIOMILLENIA’s disruptive BIOMILLENIA DIMENSION 300X platform, based on licensed technology that was developed by Harvard University, the BROAD Institute and ESPCI Paris, uniquely combines advanced genomics and bioinformatics technologies with microfluidics- based ultrahigh-throughput screening. This unique technology platform delivers novel microbes, production strains and enzymes for manufacture of chemicals and natural products at throughputs and speeds several orders of magnitudes higher than with traditional methods. BIOMILLENIA “Unlocks Nature’s Potential” for cost-competitive and sustainably manufactured novel biology-based products for a better life.

biotechrabbit GmbH was founded in 2011 in Henningsdorf; already 4 years later, in 2015, a second research and production site was opened in Berlin / Adlershof. biotechrabbit is a team of top class scientists, experienced managers and business developers who are determined to offer highest quality products and services for diagnostic companies and life science research. We value the relationships with our partners and customers and are driven to exceed current limitations with flexibility, innovation and highly customized solutions to match specific requirements.
biotechrabbit’s offering includes enzymes for molecular diagnostics, antibody generation and production, high-capacity protein fermentation, lyophilization for diagnostic test kits and pharma, highly parallel, cell-free protein synthesis, mRNA for therapeutics, site-directed amino acid incorporation for labeling or cancer biotherapeutics and a full molecular biology products catalog.
Our way of doing business combines the passion and pure curiosity of excellent researchers with the agile spirit of true entrepreneurs.

bitop AG is a biotechnology company focused on products based on extremolytes, a group of natural protective molecules responsible for the stress resistance of extremophilic microorganisms. bitop develops and employs fermentative and biocatalytic bioprocesses for extremolyte production.
The company offers innovative medical devices based on the extremolyte Ectoin® in the areas of allergy, dermatology, respiratory diseases and dry epithelia with scientifically confirmed efficacy and tolerability. Furthermore, bitop offers extremolyte products like Ectoin®, Glycoin®, and 28Extremoin® as cosmetic active ingredients as well as hydroxyectoin as biostabilizer for diagnostics and life sciences.

BluCon Biotech entwickelt eine einzigartige Technologie zur Herstellung von L-Milchsäure aus land- oder forstwirtschaftlichen Reststoffen wie Stroh oder Holz durch direkte Fermentation mit ihren proprietären extremophilen Produktionsbakterien.  Ziel ist es zu ermöglichen, dass der Biokunststoff Polymilchsäure (PLA) auf nachhaltige Weise und wirtschaftlich wettbewerbsfähig zu konventionellen Verpackungskunststoffen hergestellt werden kann.

BluCon Biotech arbeitet mit einem Netzwerk von Experten, akademischen Arbeitsgruppen und Firmen zusammen, um die Verfahrensentwicklung so rasch und effizient wie möglich abzuschließen. BluCon Biotech ist offen für eine Erweiterung der Partnerschaften, “upstream” in Richtung Rohstoffe und “downstream” in Richtung Endprodukt (PLA).

Capricorn Partners is a European manager of venture capital and equity funds, investing in innovative companies with technology as competitive advantage. With its team of seasoned investment managers with deep and broad technology expertise, Capricorn Partners invests out of the venture capital funds Capricorn Digital Growth Fund, Capricorn Sustainable Chemistry Fund, Capricorn ICT Arkiv and Capricorn Health-tech Fund. Jointly with Capricorn Scorpio Investment Management in China, Capricorn Partners acts as the exclusive investment advisor of the China-Belgium (Europe) Technology Innovative Industry Fund. It is the management company of Quest for Growth, quoted on NYSE Euronext Brussels, and the investment manager of Quest Cleantech Fund and Quest+, sub-funds of Quest Management SICAV.

Carbon Minds ist ein Data Analytics Startup. Wir nutzen unser digitales Modell der globalen Chemie- und Kunststoffindustrie, um Transparenz in den Umweltauswirkungen globaler chemischer Wertschöpfungsketten zu schaffen. Unser Modell umfasst Tausende von Chemieproduzenten, die für mehr als 80% der weltweiten Klimaauswirkungen der Branche verantwortlich sind. Auf Basis anlagenspezifischer Daten können wir detailliert regionale Unterschiede in den ökologischen Auswirkungen der Produktion einer Vielzahl von Chemikalien aufzeigen. Dadurch schaffen wir eine solide Datenbasis für Lebenszyklusanalysen und firmenweite ökologische Bewertungen. Neben der Bereitstellung von Daten erstellt Carbon Minds zudem digitale Zwillinge komplexer integrierter Produktionsstandorte und nutzt neuartige Optimierungsansätze, um kosteneffiziente Möglichkeiten für Emissionseinsparungen aufzudecken.

c-LEcta is a leading industrial biotechnology company, using best-in-class biotechnologies to efficiently provide customized enzymes and microbial strains to industrial applications. Scientific excellence is combined with in-depth commercial and regulatory know-how to bring innovative and competitive bioprocessed products into scale. Besides our in- house project and product pipeline we have a strong focus on strategic cooperation with industrial partners.
Moreover, c-LEcta is an established enzyme supplier, manufacturing unique, quality- controlled enzyme products on large technical scale.

CO2 BioClean prevents the release of industrial CO2 emissions by capturing them before their release into the atmosphere. The CO2 is transformed into 100% biodegradable biopolymer (PHA) via an efficient fermentation process. Making use of this polymer, a versatile set of items ranging from textile fibres, packaging items and interior design can be produced. The fermentation process used to produce the biodegradable polymers allows to tune the properties of the PHA such as aesthetics and mechanical properties, ranging from rigid to flexible, soft-touch and adhesive. This way, we can address requirements of complex end use applications.

Concord Blue is a waste management company that transforms nearly any form of local waste into a variety of clean, renewable fuels. Concord Blue has developed a revolutionary closed-loop system that efficiently and cost-effectively produces the highest quality sustainable energy with virtually no pollutants. Unlike other available waste-to-energy processes, Concord Blue’s unique technology benefits the environment, fulfilling all international, EPA and European regulations for renewable energy and air emissions.

Corvay berät Konzerne, mittelständige und kleine Unternehmen.  Corvay hilft beim Aufbau und baut selbst neue Geschäfte auf.  Beispiele sind das Biotechcluster BioRegioN, Aufbau und Verkauf der Vakzine Projekt Management, Aufbau und Führung der BluCon Biotech, Köln. Kürzlich wurde die Corvay Bioproducts, Leuna, gegründet, eine Entwicklungsfirma für Bioprozesse. Unsere Handelsfirma Corvay Specialty Chemicals vertreibt langkettige aliphatische Dicarbonsäuren sowie Spezialenzyme an die chemische Industrie, und Vitamin D3 an Nahrungs- und Futtermittelfirme. Wir sind interessiert an der Erweiterung unseres Portfolios.  Corvay´s Mehrwert für Ihr Unternehmen: 1. Hochleistung seit fast 20 Jahren, 2. Internationale, operationelle Management Erfahrung 3. ein sehr effizientes Netzwerk.

DASGIP has been an industry-leading supplier of benchtop bioreactor solutions for the biotech, pharmaceutical and chemical industries as well as academia and research institutions since 1991. Our parallel bioreactor systems for the cultivation of microbial, plant, animal and human cells utilize industry-standard benchtop glass and single-use bioreactors.
DASGIP’s best-in-class configurable control systems and state-of-the-art bioprocess analyzers deliver unparalleled functionality coupled with user-friendly design for optimal bioprocessing. Our proven solutions for interconnectivity to 3rd party bioprocess analyzers, supervisory control systems and DoE tools, combined with our best-in- class control systems, enable migration strategies for optimization of legacy benchtop bioreactor equipment.
The outstanding DASGIP bioprocess solutions support QbD-driven process development. As of January 2012, DASGIP is an Eppendorf company. DASGIP is headquartered in Juelich (Germany) and has operations throughout Europe, North America and Asia.

Dutch DNA Biotech (DDNA) started in 2015 as a management buyout from The Netherlands Organization for Applied Scientific Research (TNO) with the mission to contribute to the society by developing sustainable fungi-based production processes for innovative products.
DDNA is focused on the development of fungal strains and fermentation processes for the production of proteins and organic acids.
DDNA has a mixed business model; in addition to contract research DDNA develops proprietary technology which is out-licensed.
The R & D team consists of molecular biologists and fermentation experts; eight of them have a PhD. The CSO, Professor Peter Punt, holds a chair at Leiden University. DDNA has a seasoned management. The company is based at the Science Park of Utrecht University, The Netherlands

Der Innovationsraum BioBall fördert Technologien zur stofflichen Nutzung von biogenen Stoff- und Abfallströmen und fokussiert sich dabei insbesondere auf die Herausforderungen und Chancen einer dicht besiedelten, industrialisierten Metropolregion wie der Region Frankfurt/ RheinMain. Der Verein intensiviert den direkten Austausch von privater und kommunaler Wirtschaft, Wissenschaft und Politik – stößt neue Projektideen an und fördert mit Mitteln des BMBF innovative Forschungs- und Entwicklungsvorhaben, um eine biobasierte Wirtschaft zu etablieren. Dadurch lassen sich nicht nur Rohstoffkreisläufe schließen, Treibhausgasemissionen minimieren – sondern auch wirtschaftlich ungenutzte Potentiale heben.

BCNP Consultants GmbH is specialized in the industries biotech, chemistry, nanotech and pharma (BCNP). The three divisions of BCNP Consultants are:
BCNP strategy
On basis of our business analyses (market and competitor analysis, technology comparisons) you are able to design and sharpen your business model, to write the business case and to identify new M&A targets.
BCNP connect
On the basis of our vivid business networks in the life sciences industry we bring you together with relevant people in order to support you in filling your customer pipeline.
European Chemistry Partnering
Since 2017 innovators – from chemistry to bio-economy, from engineering to digitization – have been meeting twice a year: In February at the European Chemistry Partnering and in September at the ECP Summer Summit.

As a not-for-profit organisation, Bioindustrial Innovation Canada (BIC) supports Ontario and Canada become globally recognized leaders in the field of sustainable technologies. With a vision to create jobs and economic value sustainably for Canada, BIC provides critical strategic investment, advice and services to business developers of clean, green and sustainable technologies. In Sarnia and Lambton County, a true hybrid cluster has developed around sustainable chemistry, based on fostering partnerships and bringing the right individuals together from industry, colleges, universities and governments to support the development of the cluster.
In 2016, BIC established the Centre for Commercialization of Sustainable Chemistry Innovation (COMM SCI) initiative program, which acts as a hub for the commercialisation of sustainable chemistry and bio-based innovation. BIC’s proven expertise in commercialisation is the differentiator that will enable us to build a stronger and more sustainable Canada.

BioIndustry e.V. is a registered association whose main purpose is to activate, concentrate and develop biotechnological competencies in the Ruhr region. The key aspects of BioIndustry‘s activity are industrial biotechnology and bioprocessing technologies, microstructure technology, X-omics and bioinformatics. As a networking service cluster of 50 companies, research and training institutes, technology centres, biotechnological service providers and public business development organisations, the associations objective is to generate product- and process-innovations. This objective will be met by supporting the active transfer from ideas to market.

BioRiver – Joining forces for Life Sciences & Biotechnology
Founded in 2004, BioRiver – Life Science im Rheinland e.V. is fully committed to representing the Life Sciences sector in the bioregion Rhineland as an independent industry organisation. The essential aims of BioRiver are to build a strong network within the biotech sector, to improve the political and economic conditions as well as to market the bioregion Rhineland and its members. Thanks to the strong profiles of the partners in the network, it has been possible to initiate various collaboration projects and gain direct access to experts in both business and academia.

The chemical department of the intellectual property law firm Eder Schieschke & Partner mbB has specialized in representing clients in the field of organic chemistry, biochemistry and biotechnology before the European Patent Office, the German Patent and Trademark Office, the German Patent Court and the European Intellectual Property Organization in all areas of intellectual property law.
Amongst obtaining patent rights, utility model rights and trademark rights Eder Schieschke & Partner mbB’s expertise is also directed to license agreements, preparation of invalidity, infringement and freedom-to-operate studies, as well as German employee law.
As a member of CLIB, Eder Schieschke & Partner mbB is supporting the Cluster with the realization of IP coaching seminars for start-ups and SMEs.

The Industrial Biotechnology Innovation Centre’s (IBioIC) role, as a specialist in the Industrial Biotechnology (IB) sector, is to stimulate the growth of the IB sector in Scotland to £900 million by 2025. IBioIC connects industry, academia and government, and facilitates collaborations, provides scale-up capabilities, creates networks, and develops skills.
IBioIC supports transition into IB by helping companies to understand the benefits and opportunities, overcome any barriers and to make sure our members are in touch with the right people to guide them through the technology and its consequent translation and implementation in their business.

Eindhoven University of Technology (TU/e) is a research university, founded in 1956, specializing in engineering science & technology. The Department of Chemical Engineering and Chemistry aspires to be an academic institution for education and research in chemical science and engineering of the highest international standard. The aim is to generate and to develop technology and scientific knowledge relevant for the long-term needs of society.
Scientific curiosity and the use of newly generated knowledge are the main driving forces behind the continuing enhancement of our expertise in (electro-)chemical reactor engineering, multiscale & multiphase modelling, process intensification, membrane processes and heterogeneous catalysis.

Russian Academy of Sciences was organized through merging the A.N. Bach Institute of Biochemistry RAS (INBI RAS), the S.N. Winogradsky Institute of Microbiology RAS and the Centre «Bioengineering» RAS.
The Research Centre of Biotechnology RAS carries out basic and applied research in the fields of biochemistry and biotechnology, microbiology, genomics, bioengineering and genetic engineering, biocatalysis, system and structural biology, biogeotechnologies, bioremediation, agrobiotechnologies, food quality and safety.
The Centre is the key member of the Russian Technology Platform «Bioindustry and Bioresources–BioTech2030». The Russian National Contact Point on Biotechnology, three core facilities, an accredited testing laboratory, and an experimental greenhouse are functioning at the Centre.

Within “Sustainable Chemistry”, VITO focuses on process intensification and replacing fossil with sustainable resources. Key is the integration of conversion with separation processes to improve overall efficiency and sustainability: in situ product recovery within biocatalytic processes, biocatalyst immobilization, and novel separation approaches (membranes are often integrated in these processes) are some of our developments in this field.
Using alternative resources (like CO2 or biomass) requests different approaches to deliver high added value products: mild disclosure, (scCO2) extraction, fractionation and biocatalytic processes, (bio)electrochemical reactions with CO2. VITO is one of the partners involved in the inventories and strategic research agenda for “Sustainable Chemistry” especially in the Flemish (CATALISTI) and European context (BIG-Cluster, SPIRE, BBI, SusChem), but also on a global level (India). VITO is also founding partner of Biorizon, a shared research center for bio-aromatics.

IBG-1: Biotechnology is a leading institute in the field of microbial biotechnology and biocatalysis. Multipurpose microbial production platforms (e. g. C. glutamicum, P. putida) are used for the production of industrially, nutritionally or pharmaceutically relevant products (bulk / fine chemicals, natural products, enzymes/proteins) from renewable carbon sources. Methods of synthetic biology are used for establishing novel concepts in strain development and engineering of metabolic pathways. Moreover, multi-step enzyme cascades for cell-free biosynthesis are developed.
Process development is based on lab automation systems combined with extensive digitalization. IBG-1 runs an extensive “omics” platform (sequencing, proteomics, metabolomics and fluxomics) for strain characterization and a single-cell analysis lab. Microbial cultivation facilities range from microfluidic devices over parallelized mini bioreactor systems up to pilot plant scale. Lab investigations are tightly integrated with mathematical modelling, data analysis, experimental design and process optimization.

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB develops and optimizes processes and products in the fields of health, sustainable chemistry and environment. Main topics in the sustainable chemistry field are biobased chemicals and materials, the utilization of CO2 and chemical recycling as well as modular plant construction and demonstration.
In the area of Industrial Biotechnology we focus on establishing, optimising and scaling up processes that take place with the help of enzymes or microorganisms. In some cases, the desired conversion also becomes possible through combination with chemical transformation processes. In the development of the conversion processes under laboratory conditions and the optimisation of the biocatalysts, the focus is already on scaling up the processes and processing the products. At the Fraunhofer Center for Chemical-Biotechnological Processes CBP, the Leuna branch of the institute, infrastructure and pilot plants are available to scale up processes to production-relevant dimensions.

The Fraunhofer Institute for Molecular Biology and Applied Ecology IME conducts research in the field of applied life sciences from a molecular level to entire ecosystems. By strategic orientation along the value chain, the Fraunhofer IME follows the mission to take innovative products closer towards the market, to develop enabling technologies, and provide scientific services to partners from academic institutions and industry.
In the area of industrial biotechnology, the Fraunhofer IME offers research in the field of directed evolution, classical strain improvement, metabolic pathway engineering, and fermentation. Besides scientific expertise, we possess state-of-the-art facilities for high-throughput screening, enzyme production & purification, fermentation process development, and protein crystallization and modelling.

Der Wandel zu einem nachhaltigen und klimaneutralen Wirtschaftssystem erfordert Verantwortung, großes Engagement und die Kooperation aller gesellschaftlichen Gruppen. Das Fraunhofer UMSICHT erforscht und entwickelt gemeinsam mit Partnerinnen und Partnern klimaneutrale Energiesysteme, ressourceneffiziente Prozesse und zirkuläre Produkte. Wir bieten verfahrenstechnische Forschungs- und Entwicklungsdienstleistungen inkl. Schutzrechte in Chemie, Petrochemie, Raffinerie und Hüttenindustrie an. Unser Know-how umfasst die Bereiche Fein- und Spezialchemikalien, chemische Massenprodukte und Biokraftstoffe. Biomasse, Synthesegas und ausgewählte Reststoffe bilden das Portfolio an Rohstoffen. Know-how über die vor- und nachgelagerte Verarbeitung sowie die Produktformulierung runden unsere Kompetenz ab.